Survival rates with two approaches were similar, but one came with more complications ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

Learn about prostate cancer, its diagnosis, treatment options, and the latest study findings. Understand which types need ...

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

But an association with improved overall survival failed to reach statistical significance ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers.

These results suggest that oxybutynin may offer a practical and effective option for managing ADT-associated hot flashes in ...

Metastasis-directed therapy for oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...